Study on the anti-colorectal cancer efficacy of the paclitaxel/oxaliplatin co-delivery system

A biotin-modified polyethylene glycol–paclitaxel nanocarrier was developed for the co-delivery of paclitaxel and oxaliplatin in colorectal cancer therapy. The biotin–PEG–PTX copolymer was synthesized and characterized by FTIR spectroscopy, and paclitaxel nanoparticles and oxaliplatin-loaded nanoparticles were prepared through self-assembly. Their physicochemical properties, stability, morphology, and drug-release behavior were evaluated using DLS, TEM, and in vitro release assays. OXA@PTX nanoparticles inhibited HCT-116 cell growth, showed combination-associated cytotoxicity and time-dependent nanoparticle-associated fluorescence, and produced lower macrophage-associated fluorescence than free FITC under the tested conditions. In tumor-bearing mice, the formulation showed qualitatively greater tumor-associated fluorescence, reduced Ki-67 expression, and increased TUNEL staining, with no obvious histopathological abnormalities in major organs. The nanocarrier also exhibited sustained, pH-dependent drug release, supporting its potential as a biotin-functionalized platform for paclitaxel and oxaliplatin co-delivery in colorectal cancer therapy.

Authors

Publication Details

Journal
Figshare
Published
2026-11-19
DOI
https://doi.org/10.6084/m9.figshare.35061611
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Study on the anti-colorectal cancer efficacy of the paclitaxel/oxaliplatin co-delivery system

Chunlian He, Qinyan Xie, Ruiyi Tan, Ziqin Zeng et al.
Figshare
Nanoparticle-Based Drug Delivery
article

Study on the anti-colorectal cancer efficacy of the paclitaxel/oxaliplatin co-delivery system

Chunlian He, Qinyan Xie, Ruiyi Tan, Ziqin Zeng, Yangfen Fu, Lewei Li, Hao Deng, Xiuteng Cao, Benjie Zhang, Yuxin Li, Jiaxin Yin, Song Chen
article en

Abstract

A biotin-modified polyethylene glycol–paclitaxel nanocarrier was developed for the co-delivery of paclitaxel and oxaliplatin in colorectal cancer therapy. The biotin–PEG–PTX copolymer was synthesized and characterized by FTIR spectroscopy, and paclitaxel nanoparticles and oxaliplatin-loaded nanoparticles were prepared through self-assembly. Their physicochemical properties, stability, morphology, and drug-release behavior were evaluated using DLS, TEM, and in vitro release assays. OXA@PTX nanoparticles inhibited HCT-116 cell growth, showed combination-associated cytotoxicity and time-dependent nanoparticle-associated fluorescence, and produced lower macrophage-associated fluorescence than free FITC under the tested conditions. In tumor-bearing mice, the formulation showed qualitatively greater tumor-associated fluorescence, reduced Ki-67 expression, and increased TUNEL staining, with no obvious histopathological abnormalities in major organs. The nanocarrier also exhibited sustained, pH-dependent drug release, supporting its potential as a biotin-functionalized platform for paclitaxel and oxaliplatin co-delivery in colorectal cancer therapy.

Figshare
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon